Finance
Banking, Economy & Business
Latest Articles (10000)
A $3 Trillion Question: How Fragile Is Private Credit?
Zebra Technologies Bridges The Gap Between Human And Robot
Kailera makes history with record-breaking $625m IPO
Kailera makes history with record-breaking $625m IPO
Procter & Gamble: Solid Fundamentals, But Valuation Keeps Me On Hold
Realty Income: An Attractive Holding In A Dividend Portfolio, But Fully Valued
SMH: 12-Day Winning Streak, And Why I See More Gains Ahead For Chip Stocks
Robinhood Surges 6%: A Landmark SEC Rule Change Fuels the Rally but Schwab’s Crypto Launch Looms Large
Robinhood Surges 6%: A Landmark SEC Rule Change Fuels the Rally but Schwab’s Crypto Launch Looms Large
Driehaus Small Cap Growth Strategy Q1 2026 Commentary
The MSC Income Fund Is Not On Par With Main Street Capital
Kraken to buy derivatives exchange Bitnomial for $550m in latest acquisition
Kraken to buy derivatives exchange Bitnomial for $550m in latest acquisition Mathew Di Salvo Fri, April 17, 2026 at 8:22 AM PDT 2 min read KRAK.PVT Kraken’s parent company, Payward, will buy derivativ...
Prologis ups 2026 outlook as warehouse demand strengthens
Prologis ups 2026 outlook as warehouse demand strengthens
Here's Why D-Wave Quantum Stock Soared This Week
Here's Why D-Wave Quantum Stock Soared This Week
Stock Market Leaders Emerge In IBD 50, Rise In Volume After Follow-Through Day
The S&P 500's follow-through day on April 8 came in the middle of a 12-session win streak for the Nasdaq composite — its longest since 2009. And big volume has picked up in new stock market leaders th...
Trump's Iran Strategy Puts Palantir in the Spotlight -- but Is This Defense‑Data Stock Built for Long‑Term Investors?
Trump's Iran Strategy Puts Palantir in the Spotlight -- but Is This Defense‑Data Stock Built for Long‑Term Investors?
Bright Prospects Ahead for Abivax (ABVX)
Bright Prospects Ahead for Abivax (ABVX)
AI Chips Used to Be Nvidia’s Game. Now More Winners Are Emerging.
GRX’s 14-Year Dividend Streak Holds Firm as Rate Cuts Ease Leverage Costs
GRX’s 14-Year Dividend Streak Holds Firm as Rate Cuts Ease Leverage Costs
Bright Outlook for Nektar Therapeutics (NKTR) Hinges on Positive Trial Results
Bright Outlook for Nektar Therapeutics (NKTR) Hinges on Positive Trial Results
Why Qualys (QLYS) Is Facing New Pressure In The AI Era — TD Cowen’s $90 Target
Why Qualys (QLYS) Is Facing New Pressure In The AI Era — TD Cowen’s $90 Target